Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic tolerance

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5789-5801

  Chappell, Craig P ^a   Giltiay, Natalia V ^a   Draves, Kevin E ^a   Chen, Chang Hung ^b   Hayden Ledbetter, Martha S ^a   Shlomchik, Mark J ^c   Kaplan, Daniel H ^d   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ElAb Bio   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLOOD DENDRITIC CELL ANTIGEN 2; CELL ANTIGEN; INTERLEUKIN 12; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; IMMUNOLOGICAL TOLERANCE; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PLASMA CELLS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 84902205646     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303259     Document Type: Article

References (66)

1. Chappell, C. P., N. V. Giltiay, C. Dresch, and E. A. Clark. 2014. Controlling immune responses by targeting antigens to dendritic cell subsets and B cells. Int. Immunol. 26:3-11.
2. Caminschi, I., M. H. Lahoud, and K. Shortman. 2009. Enhancing immune responses by targeting antigen to DC. Eur. J. Immunol. 39:931-938.
3. Kreutz, M., P. J. Tacken, and C. G. Figdor. 2013. Targeting dendritic cells: why bother? Blood 121:2836-2844.
4. Geijtenbeek, T. B., S. J. Van Vliet, A. Engering, B. A. 't Hart, and Y. Van Kooyk. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22:33-54.
5. Garcia-Vallejo, J. J., and Y. Van Kooyk. 2013. The physiological role of DCSIGN: a tale of mice and men. Trends Immunol. 34:482-486.
6. Pyz, E., A. S. Marshall, S. Gordon, and G. D. Brown. 2006. C-type lectin-like receptors on myeloid cells. Ann. Med. 38:242-251.
7. Engering, A., T. B. Geijtenbeek, S. J. Van Vliet, M. Wijers, E. Van Liempt, N. Demaurex, A. Lanzavecchia, J. Fransen, C. G. Figdor, V. Piguet, and Y. Van Kooyk. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2118-2126.
8. Gijzen, K., A. Cambi, R. Torensma, and C. G. Figdor. 2006. C-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates. Curr. Protein Pept. Sci. 7:283-294.
9. Burgdorf, S., A. Kautz, V. Böhnert, P. A. Knolle, and C. Kurts. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316:612-616.
10. + myeloid dendritic cells. Blood 119:2284-2292.
11. Sancho, D., and C. Reis E Sousa. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30:491-529.
12. Kerrigan, A. M., and G. D. Brown. 2011. Syk-coupled C-type lectins in immunity. Trends Immunol. 32:151-156.
13. Zhang, J., A. Raper, N. Sugita, R. Hingorani, M. Salio, M. J. Palmowski, V. Cerundolo, and P. R. Crocker. 2006. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107:3600-3608.
14. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171-1178
15. Blasius, A. L., E. Giurisato, M. Cella, R. D. Schreiber, A. S. Shaw, and M. Colonna. 2006. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177:3260-3265.
16. Blasius, A. L., M. Cella, J. Maldonado, T. Takai, and M. Colonna. 2006. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107:2474-2476.
17. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835-1837.
18. Kadowaki, N., S. Antonenko, J. Y. Lau, and Y. J. Liu. 2000. Natural interferon a/b-producing cells link innate and adaptive immunity. J. Exp. Med. 192:219-226.
19. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919-923.
20. Barchet, W., M. Cella, B. Odermatt, C. Asselin-Paturel, M. Colonna, and U. Kalinke. 2002. Virus-induced interferon a production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 195:507-516.
21. Villadangos, J. A., and L. Young. 2008. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29:352-361.
22. Krug, A., R. Veeraswamy, A. Pekosz, O. Kanagawa, E. R. Unanue, M. Colonna, and M. Cella. 2003. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 197:899-906.
23. Tel, J., A. J. Lambeck, L. J. Cruz, P. J. Tacken, I. J. De Vries, and C. G. Figdor. 2010. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen. J. Immunol. 184:4276-4283.
24. Di Pucchio, T., B. Chatterjee, A. Smed-Sórensen, S. Clayton, A. Palazzo, M. Montes, Y. Xue, I. Mellman, J. Banchereau, and J. E. Connolly. 2008. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9:551-557.
25. Salio, M., M. J. Palmowski, A. Atzberger, I. F. Hermans, and V. Cerundolo. 2004. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J. Exp. Med. 199:567-579.
26. Yu, C. F., W. M. Peng, J. Oldenburg, J. Hoch, T. Bieber, A. Limmer, G. Hartmann, W. Barchet, A. M. Eis-Hübinger, and N. Novak. 2010. Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation. J. Immunol. 184:1159-1167.
27. Loschko, J., and A. Krug. 2012. Antigen delivery to plasmacytoid dendritic cells: induction of tolerance and immunity. Crit. Rev. Immunol. 32:489-501.
28. Ito, T., M. Yang, Y. H. Wang, R. Lande, J. Gregorio, O. A. Perng, X. F. Qin, Y. J. Liu, and M. Gilliet. 2007. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204:105-115.
29. + regulatory T cells. J. Immunol. 173:4433-4442.
30. Boonstra, A., C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y. J. Liu, and A. O'Garra. 2003. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation. J. Exp. Med. 197:101-109.
31. + cytotoxic regulatory T cells. Blood 107:1031-1038.
32. Swiecki, M., and M. Colonna. 2010. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234:142-162.
33. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-6046.
34. Jaehn, P. S., K. S. Zaenker, J. Schmitz, and A. Dzionek. 2008. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Eur. J. Immunol. 38:1822-1832.
35. Dzionek, A., Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Günther, I. Johnston, A. Lanzavecchia, T. Nagasaka, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J. Exp. Med. 194:1823-1834.
36. Cao, W., L. Zhang, D. B. Rosen, L. Bover, G. Watanabe, M. Bao, L. L. Lanier, and Y. J. Liu. 2007. BDCA2/FcεRI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 5:e248.
37. Hardy, R. R. 1986. Purification and coupling of fluorescent proteins for use in flow cytometry. In Handbook of Experimental Immunology, 4th Ed. D. M. Weir, L. A. Herzenberg, C. Blackwell, and L. A. Herzenberg, eds. Blackwell Scientific Publications, Boston, p-31-1-31-12.
38. Goins, C. L., C. P. Chappell, R. Shashidharamurthy, P. Selvaraj, and J. Jacob. 2010. Immune complex-mediated enhancement of secondary antibody responses. J. Immunol. 184:6293-6298.
39. Chappell, C. P., K. E. Draves, N. V. Giltiay, and E. A. Clark. 2012. Extrafollicular B cell activation by marginal zone dendritic cells drives T celldependent antibody responses. J. Exp. Med. 209:1825-1840.
40. Kerkmann, M., S. Rothenfusser, V. Hornung, A. Towarowski, M. Wagner, A. Sarris, T. Giese, S. Endres, and G. Hartmann. 2003. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170:4465-4474.
41. Jáhn, P. S., K. S. Zánker, J. Schmitz, and A. Dzionek. 2010. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation. Cell. Immunol. 265:15-22.
42. + T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 177:2276-2284.
43. Lahoud, M. H., F. Ahmet, S. Kitsoulis, S. S. Wan, D. Vremec, C. N. Lee, B. Phipson, W. Shi, G. K. Smyth, A. M. Lew, et al. 2011. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J. Immunol. 187:842-850.
44. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
45. Matta, B. M., A. Castellaneta, and A. W. Thomson. 2010. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40:2667-2676.
46. Loschko, J., S. Heink, D. Hackl, D. Dudziak, W. Reindl, T. Korn, and A. B. Krug. 2011. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity. J. Immunol. 187:6346-6356.
47. + T regulatory cells. J. Immunol. 184:3433-3441.
48. + regulatory T cells. J. Immunol. 181:6923-6933.
49. Kretschmer, K., T. S. Heng, and H. Von Boehmer. 2006. De novo production of antigen-specific suppressor cells in vivo. Nat. Protoc. 1:653-661.
50. + T regulatory cells. J. Immunol. 176:3301-3305.
51. Macauley, M. S., F. Pfrengle, C. Rademacher, C. M. Nycholat, A. J. Gale, A. Von Drygalski, and J. C. Paulson. 2013. Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J. Clin. Invest. 123:3074-3083.
52. Hadeiba, H., T. Sato, A. Habtezion, C. Oderup, J. Pan, and E. C. Butcher. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9:1253-1260.
53. Zou, W., V. Machelon, A. Coulomb-L'Hermin, J. Borvak, F. Nome, T. Isaeva, S. Wei, R. Krzysiek, I. Durand-Gasselin, A. Gordon, et al. 2001. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7:1339-1346.
54. De Heer, H. J., H. Hammad, T. Soullié, D. Hijdra, N. Vos, M. A. Willart, H. C. Hoogsteden, and B. N. Lambrecht. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200:89-98.
55. Jongbloed, S. L., R. A. Benson, M. B. Nickdel, P. Garside, I. B. McInnes, and J. M. Brewer. 2009. Plasmacytoid dendritic cells regulate breach of selftolerance in autoimmune arthritis. J. Immunol. 182:963-968.
56. Chen, W., X. Liang, A. J. Peterson, D. H. Munn, and B. R. Blazar. 2008. The indoleamine 2, 3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181:5396-5404.
57. Jahrsdórfer, B., A. Vollmer, S. E. Blackwell, J. Maier, K. Sontheimer, T. Beyer, B. Mandel, O. Lunov, K. Tron, G. U. Nienhaus, et al. 2010. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 115:1156-1165.
58. Tel, J., S. P. Sittig, R. A. Blom, L. J. Cruz, G. Schreibelt, C. G. Figdor, and I. J. De Vries. 2013. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion. J. Immunol. 191:5005-5012.
59. Tel, J., D. Benitez-Ribas, S. Hoosemans, A. Cambi, G. J. Adema, C. G. Figdor, P. J. Tacken, and I. J. De Vries. 2011. DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur. J. Immunol. 41:1014-1023.
60. Meyer-Wentrup, F., D. Benitez-Ribas, P. J. Tacken, C. J. Punt, C. G. Figdor, I. J. De Vries, and G. J. Adema. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-a production. Blood 111:4245-4253.
61. St Pierre, C. A., D. Leonard, S. Corvera, E. A. Kurt-Jones, and R. W. Finberg. 2011. Antibodies to cell surface proteins redirect intracellular trafficking pathways. Exp. Mol. Pathol. 91:723-732.
62. + suppressor T cells in vivo. Nat. Immunol. 3:33-41.
63. + T cells. Blood 119:5155-5163.
64. Lee, K. M., E. Chuang, M. Griffin, R. Khattri, D. K. Hong, W. Zhang, D. Straus, L. E. Samelson, C. B. Thompson, and J. A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282:2263-2266.
65. Schneider, H., J. Downey, A. Smith, B. H. Zinselmeyer, C. Rush, J. M. Brewer, B. Wei, N. Hogg, P. Garside, and C. E. Rudd. 2006. Reversal of the TCR stop signal by CTLA-4. Science 313:1972-1975.
66. Rigby, M. R., L. A. Dimeglio, M. S. Rendell, E. I. Felner, J. M. Dostou, S. E. Gitelman, C. M. Patel, K. J. Griffin, E. Tsalikian, P. A. Gottlieb, et al; T1DAL Study Team. 2013. Targeting of memory T cells with alefacept in newonset type 1 diabetes (T1DAL study):12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol. 1:284-294